FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014576285> ?p ?o ?g. }

• W2014576285 endingPage "7" @default.
• W2014576285 startingPage "1" @default.
• W2014576285 abstract "Bevacizumab (Avastin®, Genentech, CA) was granted accelerated approval by the FDA for metastatic breast cancer in 2008. This occurred after the initial clinical trial, E2100, demonstrated an improvement in progression-free survival (PFS) and overall survival (OS) with the addition of bevacizumab to a standard chemotherapy. Unfortunately, the approval was rescinded in 2011 when two subsequent trials, AVADO and RIBBON-1, failed to show survival benefit. We compare and analyze the landmark trials E2100, AVADO and RIBBON-1, and suggest that the present-day clinical trial model may not be suited for the investigation of targeted therapies such as bevacizumab. The existing clinical trial model does not allow for modification of chemotherapeutic doses in a manner that maximizes the effect of biologic response modifiers and does not account for its “chemosensitizing” effect. The E2100, AVADO, and RIBBON-1 trials differed in the type and dose of chemotherapy, the dose and frequency of bevacizumab, and in the trial design, making it difficult to effectively compare and evaluate the results. The efficacy of combining bevacizumab with a maximum tolerated dose (MTD) of chemotherapy is also discussed in view of the observation that increased tumor response did not translate to an increase in survival. We suggest that even though angiogenesis inhibitors are non-toxic as monotherapies, they increase the toxicity of standard chemotherapy, and consequently a re-design of the now classic clinical trial model should be considered. Modifying the existing clinical trial model will lead to a more accurate evaluation of the safety and efficacy of bevacizumab and other biological agents in treating metastatic cancer." @default.
• W2014576285 created "2016-06-24" @default.
• W2014576285 creator A5035228727 @default.
• W2014576285 creator A5076482093 @default.
• W2014576285 date "2015-02-01" @default.
• W2014576285 modified "2023-10-18" @default.
• W2014576285 title "The toxicity of anti-VEGF agents when coupled with standard chemotherapeutics" @default.
• W2014576285 cites W103592546 @default.
• W2014576285 cites W1523876923 @default.
• W2014576285 cites W1539571840 @default.
• W2014576285 cites W1819686384 @default.
• W2014576285 cites W1885134561 @default.
• W2014576285 cites W1943173994 @default.
• W2014576285 cites W1964661764 @default.
• W2014576285 cites W1978139448 @default.
• W2014576285 cites W1982246723 @default.
• W2014576285 cites W1983763042 @default.
• W2014576285 cites W2006202974 @default.
• W2014576285 cites W2010293565 @default.
• W2014576285 cites W2029883816 @default.
• W2014576285 cites W2043863730 @default.
• W2014576285 cites W2049827480 @default.
• W2014576285 cites W2059050919 @default.
• W2014576285 cites W2059294866 @default.
• W2014576285 cites W2062594120 @default.
• W2014576285 cites W2085527076 @default.
• W2014576285 cites W2093498435 @default.
• W2014576285 cites W2095919269 @default.
• W2014576285 cites W2103563357 @default.
• W2014576285 cites W2121594719 @default.
• W2014576285 cites W2126275851 @default.
• W2014576285 cites W2137797191 @default.
• W2014576285 cites W2138843392 @default.
• W2014576285 cites W2140868957 @default.
• W2014576285 cites W2147328441 @default.
• W2014576285 cites W2155343550 @default.
• W2014576285 cites W2157930949 @default.
• W2014576285 cites W2163858424 @default.
• W2014576285 cites W2167224460 @default.
• W2014576285 cites W2399376965 @default.
• W2014576285 cites W2416957871 @default.
• W2014576285 cites W31811431 @default.
• W2014576285 cites W426067948 @default.
• W2014576285 doi "https://doi.org/10.1016/j.canlet.2014.10.028" @default.
• W2014576285 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5478381" @default.
• W2014576285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25449430" @default.
• W2014576285 hasPublicationYear "2015" @default.
• W2014576285 type Work @default.
• W2014576285 sameAs 2014576285 @default.
• W2014576285 citedByCount "10" @default.
• W2014576285 countsByYear W20145762852015 @default.
• W2014576285 countsByYear W20145762852016 @default.
• W2014576285 countsByYear W20145762852018 @default.
• W2014576285 countsByYear W20145762852019 @default.
• W2014576285 countsByYear W20145762852021 @default.
• W2014576285 countsByYear W20145762852022 @default.
• W2014576285 countsByYear W20145762852023 @default.
• W2014576285 crossrefType "journal-article" @default.
• W2014576285 hasAuthorship W2014576285A5035228727 @default.
• W2014576285 hasAuthorship W2014576285A5076482093 @default.
• W2014576285 hasBestOaLocation W20145762852 @default.
• W2014576285 hasConcept C126322002 @default.
• W2014576285 hasConcept C143998085 @default.
• W2014576285 hasConcept C148482608 @default.
• W2014576285 hasConcept C2776694085 @default.
• W2014576285 hasConcept C2777802072 @default.
• W2014576285 hasConcept C29730261 @default.
• W2014576285 hasConcept C535046627 @default.
• W2014576285 hasConcept C71924100 @default.
• W2014576285 hasConcept C98274493 @default.
• W2014576285 hasConceptScore W2014576285C126322002 @default.
• W2014576285 hasConceptScore W2014576285C143998085 @default.
• W2014576285 hasConceptScore W2014576285C148482608 @default.
• W2014576285 hasConceptScore W2014576285C2776694085 @default.
• W2014576285 hasConceptScore W2014576285C2777802072 @default.
• W2014576285 hasConceptScore W2014576285C29730261 @default.
• W2014576285 hasConceptScore W2014576285C535046627 @default.
• W2014576285 hasConceptScore W2014576285C71924100 @default.
• W2014576285 hasConceptScore W2014576285C98274493 @default.
• W2014576285 hasFunder F4320332161 @default.
• W2014576285 hasFunder F4320337354 @default.
• W2014576285 hasIssue "1" @default.
• W2014576285 hasLocation W20145762851 @default.
• W2014576285 hasLocation W20145762852 @default.
• W2014576285 hasLocation W20145762853 @default.
• W2014576285 hasLocation W20145762854 @default.
• W2014576285 hasOpenAccess W2014576285 @default.
• W2014576285 hasPrimaryLocation W20145762851 @default.
• W2014576285 hasRelatedWork W2008243627 @default.
• W2014576285 hasRelatedWork W2020038107 @default.
• W2014576285 hasRelatedWork W2110506075 @default.
• W2014576285 hasRelatedWork W2167750533 @default.
• W2014576285 hasRelatedWork W2417717847 @default.
• W2014576285 hasRelatedWork W2543100265 @default.
• W2014576285 hasRelatedWork W2564597380 @default.
• W2014576285 hasRelatedWork W2565906986 @default.
• W2014576285 hasRelatedWork W4221044984 @default.
• W2014576285 hasRelatedWork W4231596293 @default.

• next